Personal information

Other IDs

Scopus Author ID: 26221969800

Activities

Collapse all

Works (10)

Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug

Molecular Therapy
2020 | Journal article
DOI: 10.1016/j.ymthe.2020.06.015
EID:

2-s2.0-85087033588

Part of ISBN:

15250024 15250016
Contributors: Debacker, A.J.; Voutila, J.; Catley, M.; Blakey, D.; Habib, N.
Source: Self-asserted source
Jon Voutila via Scopus - Elsevier

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Clinical Cancer Research
2020-05-01 | Journal article
DOI: 10.1158/1078-0432.ccr-20-0414
Part of ISSN: 1078-0432
Contributors: Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; Kai-Wen Huang; Daniel H Palmer; Yuk Ting Ma; T.R. Jeff Evans et al.
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Oncogene
2018-03-07 | Journal article
DOI: 10.1038/s41388-018-0126-2
Part of ISSN: 0950-9232
Contributors: Vikash Reebye; Kai-Wen Huang; Vivian Lin; Sheba Jarvis; Pedro Cutilas; Stephanie Dorman; Simona Ciriello; Pinelopi Andrikakou; Jon Voutila; Pal Saetrom et al.
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

Molecular Therapy
2017 | Journal article
DOI: 10.1016/j.ymthe.2017.07.018
Part of ISSN: 1525-0016
Contributors: Jon Voutila; Vikash Reebye; Thomas C. Roberts; Pantelitsa Protopapa; Pinelopi Andrikakou; David C. Blakey; Robert Habib; Hans Huber; Pal Saetrom; John J. Rossi et al.
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎

Treatment of Liver Cancer by C/EBPA saRNA

RNA Activation
2017 | Other
DOI: 10.1007/978-981-10-4310-9_13
Part of ISBN: 9789811043093
Part of ISSN: 0065-2598
Contributors: Xiaoyang Zhao; Jon Voutila; Stephanos Ghobrial; Nagy A. Habib; Vikash Reebye
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎

Small activating RNA to CEBPA as a novel therapeutic approach to treat patients with liver cancer

European Journal of Cancer
2016 | Journal article
DOI: 10.1016/s0959-8049(16)33043-x
Contributors: D. Blakey; V. Reebye; J. Voutila; R. Habib; P. Saetrom; H. Huber; K.W. Huang; J. Rossi; N. Habib
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search

RNA Activation

Innovative Medicine
2015 | Other
DOI: 10.1007/978-4-431-55651-0_20
Contributors: X. Y. Zhao; J. Voutila; Nagy A. Habib; Vikash Reebye
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search

Putative Immunogenicity Expression Profiling Using Human Pluripotent Stem Cells and Derivatives

Stem Cells Translational Medicine
2015-01-09 | Journal article
DOI: 10.5966/sctm.2014-0117
Contributors: J. P. Awe; E. H. Gschweng; A. Vega-Crespo; J. Voutila; M. H. Williamson; B. Truong; D. B. Kohn; N. Kasahara; J. A. Byrne
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎

Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells

Molecular Therapy - Nucleic Acids
2012 | Journal article
DOI: 10.1038/mtna.2012.20
Contributors: Jon Voutila; Pål Sætrom; Paul Mintz; Guihua Sun; Jessica Alluin; John J Rossi; Nagy A Habib; Noriyuki Kasahara
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎

Expression profile of CREB knockdown in myeloid leukemia cells

BMC Cancer
2008-09 | Journal article
DOI: 10.1186/1471-2407-8-264
Contributors: Matteo Pellegrini; Jerry C Cheng; Jon Voutila; Dejah Judelson; Julie Taylor; Stanley F Nelson; Kathleen M Sakamoto
Source: Self-asserted source
Jon Voutila via Crossref Metadata Search
grade
Preferred source (of 2)‎
How many people are using ORCID?